T0	Drug 87 100	canagliflozin
T1	Disease 129 133	NASH
#2	AnnotatorNotes T1	DOID:0080547
T10	Chemical 531 540	glutamine
T11	Chemical 546 555	glutamate
T12	Chemical 560 567	ammonia
T13	Disease 610 615	tumor
#6	AnnotatorNotes T13	DOID:162
T14	Gene-Protein 685 687	GS
T16	Gene-Protein 845 847	GS
T17	Disease 1018 1023	tumor
T18	Drug 1074 1087	canagliflozin
T19	Drug 1230 1243	canagliflozin
T2	Gene-Protein 179 182	GS-
#13	AnnotatorNotes T2	HGNC:4341
T20	Disease 1298 1306	diabetes
#14	AnnotatorNotes T20	not found
T21	Disease 1307 1311	NASH
T22	Disease 1312 1315	HCC
T3	Disease 179 197	GS-positive tumors
#17	AnnotatorNotes T3	not found
T4	Drug 242 255	canagliflozin
T5	Gene-Protein 355 357	GS
T6	Disease 374 386	liver tumors
#20	AnnotatorNotes T6	DOID:3571
T8	Disease 472 475	HCC
T9	Gene-Protein 501 503	GS
T23	Disease 137 157	hepatocarcinogenesis
#1	AnnotatorNotes T23	DOID:3571
R1	Protects-from Arg1:T0 Arg2:T23	
T24	Gene-Protein 289 291	GS
T25	Disease 307 310	HCC
#3	AnnotatorNotes T25	DOID:684
T26	Biomarker 289 291	GS
#4	AnnotatorNotes T26	D005974
R2	Association Arg1:T26 Arg2:T25	
T27	Gene-Protein 421 423	GS
T28	Biomarker 421 444	GS in the tumor nodules
R3	Diagnostic-of Arg1:T28 Arg2:T8	
T7	Biomarker 664 698	stepwise increase of GS expression
T15	Disease 747 750	HCC
R4	Association Arg1:T7 Arg2:T15	
T29	Gene-Protein 759 761	GS
T30	Gene-Protein 804 806	GS
T31	Gene-Protein 988 991	AFP
#5	AnnotatorNotes T31	HGNC:317
T32	Gene-Protein 1121 1124	AFP
R5	Protects-from Arg1:T19 Arg2:T36	
#7	AnnotatorNotes T0	CHEMBL2048484
T34	Disease 916 936	hepatocarcinogenesis
#8	AnnotatorNotes T34	DOID:684
T35	Biomarker 845 847	GS
R6	Association Arg1:T35 Arg2:T34	
T36	Disease 1254 1274	hepatocarcinogenesis
